Tegaserod for the Treatment of Irritable Bowel Syndrome

Background: Tegaserod (Zelnorm®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C). Objective: The authors provide the reader with a bette...

Descripción completa

Detalles Bibliográficos
Autores principales: Madia, Valentina Noemi, Messore, Antonella, Saccoliti, Francesco, Tudino, Valeria, De Leo, Alessandro, De Vita, Daniela, Bortolami, Martina, Scipione, Luigi, Pindinello, Ivano, Costi, Roberta, Di Santo, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579269/
https://www.ncbi.nlm.nih.gov/pubmed/31518227
http://dx.doi.org/10.2174/1871523018666190911121306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579269/
https://www.ncbi.nlm.nih.gov/pubmed/31518227
http://dx.doi.org/10.2174/1871523018666190911121306

Ejemplares similares